Merger enforcement actions below the HSR threshold - top ten tips in non-reportable transactions

by DLA Piper
Contact

“Less is more” may be true in architecture, but in merger clearance law, “less” is still enough to trigger antitrust investigations and litigation and rescission of the whole transaction. By “less,” we mean less than the Hart-Scott-Rodino $75.9 million threshold.

The big case currently in the news underscoring this point  is FTC v. St. Luke’s Health System.  In  January 2014, the Federal Trade Commission obtained a decision from the US District Court for Idaho ordering full divestiture of a non-reportable deal more than two years after the merger had been consummated.

But that result is actually old news. Contrary to popular opinion, the antitrust agencies have a long history of challenging deals well below the Hart-Scott-Rodino thresholds, even when the deals have already closed. And with the St. Luke’s case, they are warning again that no anti-competitive deal is immune from challenge, even if it is small.

What issues should you keep in mind to prevent a future disastrous challenge from the regulators?  In this alert, we briefly discuss the highlights of St. Luke’s1 and then close with 10 important points to keep in mind  in upcoming M&A transactions.

The St. Luke’s case

St. Luke’s involved a not-for-profit health system buying a physician group in a small town in Idaho. The transaction price was only $28 million, so no HSR filing was made. According to Judge B. Lynn Winmill of the federal district court in Idaho, the evidence at trial showed that the deal produced an 80 percent market share, no prospect of new entry and a post-transaction Herfindahl-Hirschman Index over 6,200 (the agencies consider a market with an HHI of 2,500 or above to be highly concentrated).

That alone could normally be enough to condemn the transaction, but the court found other damaging facts, including internal documents that contained what were, at the very least, ambiguous justifications for the deal, like “Price Increase ($ unknown)” and “Pressure Payors for new/direct agreements.” Among other things, St. Luke’s also projected increasing revenues by escalating “office” charges to “hospital” rates. For example, the price of routine services such as x-rays or lab tests would become more expensive when billed as “hospital rates,” even when the tests were done in their original locations. This particular increase was enough, according to internal documents, to fund a 30 percent pay increase for physicians. Plus, the documents frequently used words like “clout,” leverage” and “dominance.” It is, of course, possible that these statements were taken out of context, and it also seems likely that the merger parties did not document their intentions properly. In the end, however, the existence of those statements in the parties’ internal documents was enough to sway the court to order the merger undone.

The FTC, the State of Idaho and a competing medical group all sued, claiming the $28 million deal was anti-competitive. They lost a bid for a preliminary injunction but won a decisive victory at trial. The court credited the merging parties with a sincere desire to improve the quality of health care, but it also decided that many of those improvements could have been obtained by means other than a merger. It ordered full divestiture.

St. Luke’s is appealing to the Ninth Circuit. In the meantime, the State of Idaho and the private plaintiff (a competitor) announced they want close to $10 million in legal fees from St. Luke’s. 

Challenging small transactions is an long-established Agency pattern

As disastrous as the St. Luke’s case was for the merging parties, it was absolutely predictable. The antitrust agencies have been warning for years that they will challenge anti-competitive mergers wherever they find them, including in the zone far below HSR transaction thresholds (now $75.9 million). We are not talking about deals that just skirt the HSR filing thresholds. To the contrary, we mean deals in the single digit millions. Some highlights in a range of industries:

  • In 1995, the antitrust agencies challenged a non-reportable merger where the value of the violating assets was less than $5 million (laminated tube-making)
  • In 2009, they challenged a non-reportable merger where the deal price was less than $5 million (voting machine manufacturers)
  • In 2011, they challenged a non-reportable merger where the deal price was $3.1 million (chicken processing complex)
  • In 2013, they challenged five non-reportable deals, including a $5.5 million acquisition (bleach used in municipal waste systems).

As a DOJ Antitrust Division official recently announced, from 2009 to 2013, the Division initiated 73 preliminary inquiries into deals that were not reportable under the HSR.  This made up about 20 percent of the Division’s merger investigations during that time, and more than one-fourth of those investigations resulted in a challenge to the deal.  Similar statistics also show the FTC’s willingness to unscramble even the smallest deal. The rate at which the agencies investigate non-reportable deals is growing, and the overall costs to losing merger parties can be significant because of the severity of the remedies imposed.

The top ten tips of non-reportable  transactions

Given the very real risk of an antitrust challenge to any deal with competition problems, here are 10 points to consider when facing a non-reportable transaction:

  1. Get some basic antitrust advice before the deal starts moving. The cost is minimal. The savings could be substantial.
  2. Non-reportable does not necessarily mean unnoticed. The antitrust agencies have many sources that point them to questionable deals (including competitors, customers, suppliers, journalists, state law enforcers and even disgruntled employees). The news will get out.
  3. There is no statute of limitations on unchallenged mergers. Even if the news does not get out right away, don’t hold your breath. The agencies have challenged mergers years after closing, once the anticompetitive effects became arguably clear. If the merger triggered the anticompetitive effects, it can be challenged and undone retroactively.
  4. Analyze the business reasons for the deal. Express them with care. Candidly expressed motives, perhaps laden with emotion and preserved in writing ˗ like statements that the deal will improve the ability to reduce output, “rationalize” prices, eliminate a “crazy maverick who’s disrupting  the industry” or cut off a “vicious” competitor’s supply ˗ are trouble waiting to happen.   These kinds of motives are likely to attract antitrust scrutiny.
  5. Assume that all internal documents analyzing the deal will have to be turned over to the antitrust agencies in an investigation. Puffing up the deal or the parties’ competitive significance may be good salesmanship, but risks undoing a transaction in the long run.  When ordinary-course documents predict a merger’s anticompetitive effects, the government and the courts are likely to believe them. Similarly, ambiguous statements can be misinterpreted and lead to unwanted consequences.  The same goes for documents prepared for the parties by outside consultants.  Seek counsel’s advice on how to draft documents about the deal objectively, accurately and clearly. 
  6. Quickly consummating a deal will not necessarily put you in a safer position.  The antitrust agencies are quite comfortable demanding rescission, even when it is impossible to restore the status quo. The cost and burden of “unscrambling the eggs” falls on the merger parties, not the government. As the St. Luke’s case shows, courts are willing to undo a deal even years later.
  7. A deal is not immune because it might promote some greater “public policy.” The St. Luke’s merger partners believed they were carrying out the mandate of the Affordable Care Act and promoting better health care. The judge believed they were sincere. But that didn’t stop the court from ordering a complete unwinding of the deal.
  8. Document merger-specific efficiencies.  The pro-competitive aims of the parties in St. Luke’s did them no good because the court found that the same benefits could be achieved through means other than the merger.  If a difficult merger is the only way to bring about unique pro-competitive benefits, make sure contemporaneous internal documents reflect that.
  9. Anticipate potential remedies.  In the event of an antitrust challenge, is there a limited set of measures (such as a partial divestiture or a licensing commitment) that would solve the anticompetitive problems while also preserving most of the benefits of the merger for the parties? Work with counsel to identify those potential measures and maintain the ability to deploy them if necessary.
  10. Consider pro-actively approaching the government agencies for their opinion about the deal before it is closed.  There are business review procedures at the DOJ, FTC and the state AGs that can be used for that purpose.  Get ahead of the problem before you become the problem in the eyes of the government.

Remember, you can’t buy insurance on the way to the hospital. All these points should be considered and followed from the very start of the deal. If mistakes occur in the beginning, they remain a part of the record and the antitrust agencies may well find and rely on them.


1 St. Luke’s is an excellent example of what not to do. For those interested in learning more about it, listen to this webinar led by Carl Hittinger and Steve Goff, “Sherman Antitrust Act Versus Affordable Care Act,” available here.

 

Written by:

DLA Piper
Contact
more
less

DLA Piper on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
Feedback? Tell us what you think of the new jdsupra.com!